Nanterre, 2 February 2026 VINCI awarded a hydraulic contract in Jamaica A design-build project covering 68 km of drinking water pipelines A €144 million contractA strategic project to make the country more climate resilient Jamaica’s National Water Commission (NWC) chose VINCI Construction Grands Projets to carry out a project within phase 1 of the Western Water Resilience Programme. This investment plan seeks to renovate and develop the drinking water network in the north-west of the country, where dem ...

COFACE SA: Disclosure of total number of voting rights and number of shares in the capital as at 31 January 2026 Paris, 2nd February 2026 – 17.45 Total Number of Shares CapitalTheoretical Number of Voting Rights1Number of Real Voting Rights2150,179,792150,179,792149,212,066 (1) including own shares(2) excluding own shares Regulated documents posted by COFACE SA have been secured and authenticated with the blockchain technology by Wiztrust. You can check the authenticity on the website www.wiztrust.com. Ab ...

Ivry-sur-Seine – France, February 2, 2026 Regulated information INFORMATION ON THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Statement in compliance with article L. 233-8 II of the French commercial code and article 223- 16 of the General Regulation of the French Financial Markets Authority (AMF – Autorité des marchés financiers) Stock MarketEuronext ParisISIN CodeFR0011476928Date Total number of shares composing the share capital of the companyTotal number of gross voting rights Total number of net voting ...

NEXITYSociété anonymeau capital de 280 648 620 eurosSiège Social : 67 rue Arago 93400 Saint-Ouen-sur-Seine444 346 795 RCS Bobigny Monthly disclosure of the total numberof voting rights and shares composing the share capital in accordance with Articles L. 233-8-II of the French Commercial Code and 223-16 of the General Regulation of the Autorité des Marchés Financiers Information cut-off dateTotal numberof sharesNet total number ofvoting rights31 January 2026 56,129,724 Total gross56,129,724Net total55,697,5 ...

Regulated information Paris, February 2, 2026 DISCLOSURE FISCAL 2026/13 OF TRANSACTIONS ON TREASURY SHARES Period of: January 26 to January 30, 2026 Issuer: Pluxee N.V. Class of Securities: Ordinary shares (ISIN NL0015001W49) Aggregate presentation by day and by market. Issuer CodeTransaction dateISIN CodeDaily total volume (in number of shares)Daily weighted average price of shares acquiredPlatform213800RQNIQT48SEEO8526-Jan-26NL0015001W4945 78311,1310XPAR213800RQNIQT48SEEO8526-Jan-26<td style="width:98.8 ...

JCDecaux Unveils World’s First Global Programmatic DOOH media Solution, enabling Worldwide Campaign Activations Paris, February 2nd, 2026 – JCDecaux SE (Euronext Paris: DEC), the number one outdoor advertising company worldwide, announces the global expansion of its pioneering programmatic Digital Out-of-Home (pDOOH) media solution. Building on the successful 2024 launch of the first global airport programmatic offer, JCDecaux now extends this powerful offer to street, transport, and retail environments, of ...

BATON ROUGE, La., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Lamar Advertising Company (Nasdaq: LAMR) (“Lamar” or the “Company”), a leading owner and operator of outdoor advertising assets, announced today that it had acquired the assets of Cleveland Outdoor Advertising for cash. The transaction adds 31 high-profile bulletin faces and more than 40 junior bulletin faces to Lamar's Cleveland portfolio. COA was founded 47 years ago by Debra Abdalian-Thompson and Stephen Thompson as a junior poster plant and grew to inc ...

Core Viewpoint - The net asset value (NAV) of SUTNTIB AB Tewox has decreased at the end of January 2026, indicating a decline in the company's financial performance compared to the previous month [1]. Financial Performance - The NAV at the end of January 2026 is EUR 45,333,036, down from EUR 45,679,457 at the end of December 2025, reflecting a decrease of EUR 346,421 [1]. - The share price has also decreased to EUR 1.0829 from EUR 1.0912 at the end of December 2025, indicating a decline in market valuation [1]. - The pro-forma internal rate of return (IRR) has decreased to 3.15%, down from 3.42% at the end of December 2025, suggesting a reduction in expected profitability [1].

Core Viewpoint - Reliance Global Group, Inc. has reported significant growth in Personal Lines Property and Casualty (P&C) written premium through its RELI Exchange platform, indicating strong operational momentum and the effectiveness of its expanding agency partner network [1][2][3]. Group 1: Financial Performance - Personal Lines P&C written premium increased from approximately $11.47 million in 2024 to approximately $15.6 million in 2025, representing a 36% year-over-year increase [3]. - This growth in written premium is a substantial majority of RELI Exchange's total Personal Lines premium, serving as a meaningful indicator of production trends [3]. Group 2: Agency Network Expansion - Since acquiring RELI Exchange in 2022, the company has expanded its agency partner network from approximately 65 to approximately 300 partners, driven organically through expanded distribution [4]. - The growth of the agency partner network is directly contributing to increased production and premium volumes within the RELI Exchange platform [5]. Group 3: Strategic Initiatives - The company believes that the scalability of RELI Exchange, supported by a stable foundation of revenue and cash flow, positions it to pursue transformative opportunities through its EZRA International Group platform [6][11]. - EZRA International Group focuses on identifying and acquiring high-growth technology companies, complementing the core insurance business and supporting long-term shareholder value creation [11].

CagriSema achieved superior weight loss of up to 14.2%, where up to 43% of the people achieved ≥15% weight loss and up to 24% achieved ≥20% weight loss1.CagriSema achieved superior HbA1c reduction of up to 1.91%-points1 from a mean HbA1c baseline of 8.2%.Superiority was established on both weight loss and HbA1c versus the individual components.In the trial, CagriSema appeared to have a safe and well-tolerated profile consistent with incretin and amylin-based therapies. Bagsværd, Denmark, 2 February 2026 – N ...